Warning letter
HCA The Healthcare Company: warning letter of May 3, 2001
FDA warning letter UCM069628 · Denver District Office
Key facts
| Reference number | UCM069628 |
|---|---|
| Company | HCA The Healthcare Company |
| Subject | CGMP/Blood & Blood Components |
| Issue date | May 3, 2001 |
| Posted date | May 3, 2001 |
| Issuing office | Denver District Office |
| Product type | Unknown |
| CFR sections cited | 606, 606.20, 606.100, 606.160, 606.20(b), 606.100(c) |
| Country | 3 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: